Carter Immunology Center, University of Virginia, Charlottesville, Virginia, USA.
Division of Infectious Disease and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Immunol Rev. 2023 Jul;316(1):63-83. doi: 10.1111/imr.13201. Epub 2023 Apr 4.
Rapid reaction to microbes invading mucosal tissues is key to protect the host against disease. Respiratory tissue-resident memory T (T ) cells provide superior immunity against pathogen infection and/or re-infection, due to their presence at the site of pathogen entry. However, there has been emerging evidence that exuberant T -cell responses contribute to the development of various chronic respiratory conditions including pulmonary sequelae post-acute viral infections. In this review, we have described the characteristics of respiratory T cells and processes underlying their development and maintenance. We have reviewed T -cell protective functions against various respiratory pathogens as well as their pathological activities in chronic lung conditions including post-viral pulmonary sequelae. Furthermore, we have discussed potential mechanisms regulating the pathological activity of T cells and proposed therapeutic strategies to alleviate T -cell-mediated lung immunopathology. We hope that this review provides insights toward the development of future vaccines or interventions that can harness the superior protective abilities of T cells, while minimizing the potential for immunopathology, a particularly important topic in the era of coronavirus disease 2019 (COVID-19) pandemic.
快速应对入侵黏膜组织的微生物对于保护宿主免受疾病侵害至关重要。由于呼吸道组织驻留记忆 T(T)细胞存在于病原体进入的部位,因此它们能提供针对病原体感染和/或再感染的卓越免疫力。然而,越来越多的证据表明,过度的 T 细胞反应会导致各种慢性呼吸道疾病的发展,包括急性病毒感染后的肺部后遗症。在这篇综述中,我们描述了呼吸道 T 细胞的特征以及它们的发育和维持过程。我们回顾了 T 细胞对各种呼吸道病原体的保护作用,以及它们在慢性肺部疾病(包括病毒性肺部后遗症)中的病理活性。此外,我们讨论了调节 T 细胞病理活性的潜在机制,并提出了减轻 T 细胞介导的肺部免疫病理的治疗策略。我们希望这篇综述能为开发未来的疫苗或干预措施提供一些思路,这些疫苗或干预措施可以利用 T 细胞的卓越保护能力,同时最大限度地减少免疫病理的可能性,这在 2019 年冠状病毒病(COVID-19)大流行时代是一个特别重要的课题。